Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
>,8201390,absolute neutrophil count [ANC],"In more than 600 patient-treatments, bone marrow toxicity was negligible (mean absolute neutrophil count [ANC] > 2.0 x 10(9)/L).","Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8201390/),,2.0,53802,DB04905,Tesmilifene
